Managing the Screen Failure Rate in NASH Clinical Trials: The Use of Cytokeratin 18 Assays as a Prescreening Tool
Posted: October 4, 2018
Despite the high prevalence of NAFLD, there is an overall low awareness of this disease among both providers and patients. Managing the Screen Failure Rate in NASH Clinical Trials: The Use of Cytokeratin 18 Assays as a Prescreening Tool By: Jessica Tuohy, PhD, Product Manager, Biomarkers, Diapharma Group, Inc. Posted on: October 4, 2018 in Blogs | Life Science Blogs Non‐alcoholic fatty liver dis...Read More
Xtalks Blog - Managing the Screen Failure Rate in NASH Clinical Trials: The Use of Cytokeratin 18 Assays as a Prescreening Tool
Posted: October 2, 2018
Non‐Alcoholic Fatty Liver Disease (NAFLD) is a growing global epidemic and the most common cause of liver disease in all Western countries. NAFLD refers to a spectrum of conditions and it is defined as the excessive accumulation of fat in the liver not caused by heavy alcohol consumption. Patients with Non‐Alcoholic Steatohepatitis (NASH), a more advanced form of NAFLD, are at an increased ris...Read More
60th American Society of Hematology (ASH) Annual Meeting & Exposition
Event Date: November 30 - December 1, 2018
Event Location: San Diego, CA
Diapharma is planning to attend the 60th American Society of Hematology (ASH) Annual Meeting & Exposition this year. Please click here to schedule a meeting with us or email us directly.ASH 60 The 60th ASH Annual Meeting and Exposition will be the world’s most comprehensive hematology event of 2018. The meeting will provide an invaluable educational experience and the opportunity to ...Read More
Diapharma announces new partnership with ImmunoDiagnostics (IMD)
Posted: October 1, 2018
Diapharma announces new partnership with ImmunoDiagnostics (IMD). IMD is a spin-off company from the Antibody and Immunoassay Services (AIS) division of the University of Hong Kong.ImmunoDiagnostics focuses on ImmunoMetabolism, an emerging field which studies interplay between immunological and metabolic processes, and has developed a wide range of products related to this area. IMD products hav...Read More
New Biomarkers for Liver and Kidney Toxicity Studies
Posted: September 5, 2018
Diapharma is your source for liver & kidney toxicity assaysDefend the safety of your drug candidate with new biomarkersReduce risk of unnecessary costs by preventing large clinical trials with indeterminate liver safety concernsPrevent unnecessary withdrawal or clinical hold promising new drug candidatesMost importantly, prevent delay of new medications to the marketThe use of new ...Read More
American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS PharmSci 360)
Event Date: November 4 - 7, 2018
Event Location: Walter E. Washington Convention Center, 801 Mount Vernon Pl NW, Washington, DC 20001
Diapharma is planning to attend the American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS PharmSci 360) this year. Please click here to schedule a meeting with us or email us directly.AAPS PharmSci 360 AAPS PharmSci 360 will cover all aspects of the pharmaceutical sciences. Each track will be split equally between chemical and biomolecule areas, resulting i...Read More
Society of Environmental Toxicology and Chemistry (SETAC) North America 39th Annual Meeting
Event Date: November 4 - 8, 2018
Event Location: Booth 427, Sacramento Convention Center Complex, 1400 J Street. Sacramento, CA 95814
Diapharma will attend the Society of Environmental Toxicology and Chemistry (SETAC) North America 39th Annual Meeting this year. Please click here to schedule a meeting with us or email us directly. Diapharma supplies TECO® Vitellogenin ELISAs for testing on over 25 different fish species. These assays have the ability to detect VTG protein in serum, WBH or epidermal mucus samples. Visit ...Read More
American College of Toxicology (ACT) 39th Annual Meeting
Event Date: November 4 - 7, 2018
Event Location: Palm Beach County Convention Center, 650 Okeechobee Boulevard, West Palm Beach, FL
Diapharma is planning to attend the American College of Toxicology 39th Annual Meeting this year. Please click here to schedule a meeting with us or email us directly.About The American College of Toxicology The American College of Toxicology (ACT) is a professional international organization of around 1000 research and regulatory scientists dedicated to a safer global community. These ...Read More
Diapharma announces new partnership with Haematex
Posted: September 1, 2018
Diapharma announces new partnership with Haematex.Haematex developed and patented the XACT test for assessing hypercoagulability. Haematex newest product is DOAC Stop; a vital tool for any lab troubled by new or direct oral anticoagulants (NOACs / DOACs). DOAC-Stop removes all DOACs from sample plasmas without affecting other tests of hemostasis. Its effect is best measured using Haematex’s un...Read More
Mayo Clinical Labs - Clinical and Laboratory Update in Thrombosis and Anticoagulation 2018
Event Date: October 31 - November 2, 2018
Event Location: Scottsdale, AZ
Diapharma is planning to attend the Mayo Clinical Labs – Clinical and Laboratory Update in Thrombosis and Anticoagulation 2018 meeing this year. Please click here to schedule a meeting with us or email us directly.Mayo Medical Laboratories is a global reference laboratory operating within Mayo Clinic’s Department of Laboratory Medicine and Pathology. Mayo Medical Laboratories offer...Read More
45th Canadian Ecotoxicity Workshop (CEW)
Event Date: September 30 - October 3, 2018
Event Location: Sheraton Vancouver Wall Centre, 1088 Burrard Street, Vancouver, BC, V6Z 2R9, Canada
Diapharma will attend the 45th Canadian Ecotoxicity Workshop (CEW) this year. Please click here to schedule a meeting with us or email us directly.About the 45th CEW TopicsContaminants and Ecosystem Health General Aquatic Toxicology Pesticides Toxicity of Metals and Metal Mixtures Sediment and Soil Ecotoxicity Wildlife Ecotoxicology and Disease Behavioural Toxicology Multi-Generational T...Read More
VLVbio Webinar: Cytokeratin 18 (CK18) Biomarkers in NASH Drug Development
Posted: August 28, 2018
Speaker Information: Speaker 1: Naim Alkhouri, MD Associate Professor of Medicine Division of Gastroenterology Adult & Pediatric Hepatologist, Liver Transplant Program Texas Liver InstituteDr. Alkhouri was most recently Assistant Professor of Medicine at the Cleveland Clinic Digestive Disease and Surgery Institute and Director of the Metabolic Liver Disease Clinic. He completed his medical d...Read More
On Sale! APC™ Resistance V (FV Leiden) Kits
Posted: August 8, 2018
Thinking about evaluating a new assay for your portfolio? Need to stock up for the fall? Now is the time! 50% Off Specific lots only Coatest® APC™ Resistance V N0579951, Exp. 10/31/18 To order, call 1.800.526.5224, or email info@diapharma.com Find your territory manager at diapharma.com Thank you for making us your trusted resource for over 20 years! ...Read More
Assays for IVIG Testing
Posted: July 31, 2018
Manufacturers need reliable assays to test procoagulant contaminants in IVIG preparations, in order to reduce the risk of thromboembolic events. These products from Diapharma can be used for IVIG studies and for quality checks to ensure removal of thrombogenic agents. ROX FXIa (110050) Chromogenic kit for determination of low levels of FXIa in enriched or highly purified protein...Read More
On Sale! APC Resistance V (FV Leiden) and Chromogenic FVIII Kits
Posted: July 26, 2018
Thinking about evaluating a new assay for your portfolio? Now is the time!40% Off Specific lots only Coatest® SP FVIII N1166470, Exp. 10/31/18Coatest® APC™ Resistance V N0579951, Exp. 10/31/18 To order, call 1.800.526.5224, or email info@diapharma.com Find your territory manager at diapharma.com Thank you for making us your trusted resource for over 20 yea...Read More
ASCO 2018 - Thank you from Diapharma
Posted: July 26, 2018
Diapharma welcomed the opportunity to attend the ASCO 2018 Meeting. Read on to learn about our K18 assays for measuring apoptosis in anti-cancer drug research. M30 Apoptosense® M30 CytoDeath™ M65® ELISA M65® EpiDeath Biomarkers for measuring apoptosis and necrosis in cancer researchThe M30 Apoptosense® CK18 research kit specifically detects caspase-cleaved CK1...Read More
Cambridge Healthtech Institute (CHI) Discovery on Target - NASH & Fibrosis Conference
Event Date: September 26 - 28, 2018
Event Location: Sheraton Boston Hotel, 39 Dalton St, Boston, MA 02199
Diapharma is planning to attend the NASH & Fibrosis Conference this year. Please click here to schedule a meeting with us or email us directly.The NASH and Fibrosis is organized by the Cambridge Healthtech Institute. Non-alcoholic Steatohepatitis (NASH) is a disease of the liver that starts with an accumulation of fat and proceeds to inflammation and scarring of the liver. The scarri...Read More
KININ 2018 - Thank you from Diapharma
Posted: June 25, 2018
Diapharma welcomed the opportunity to attend the KININ 2018 CLE Meeting. Read on for our showcased products: Technochrom® C1-INH For research in hereditary angioedemaChromogenic assay for simple and fast determination of C1-esterase inhibitor activity in plasma or concentrates Fully automated, bar-coded reagents available for use on the Ceveron® alpha coagulation analyzer ...Read More
1st International NASH Day
Posted: June 12, 2018
June 12th, 2018 is the 1st International NASH (Non-Alcoholic SteatoHepatitis) Day. NASH Day is organized by the NASH Education Program in order to raise awareness and learning about Non-Alcoholic SteatoHepatitis.About NASHNASH is the most severe form of non-alcoholic fatty liver disease (NAFLD). NASH is a silent, mostly asymptomatic, little-known yet widespread disease. NASH is characteriz...Read More
On Sale Now - Multiplate® Test Cells
Posted: June 1, 2018
The following products are on sale now. Select lots only. While supplies last.Product Catalog # Discount Offer ExpiresMultiplate® Test Cells 08128847001 50% OFF end of JuneBack to Featured Products. ...Read More